Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$833
|
$784B |
13.5x |
31.3x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$191
|
$491B |
5.3x |
14.4x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$230
|
$471B |
7.9x |
17.4x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$86
|
$242B |
3.7x |
8.3x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$290
|
$204B |
5.8x |
11.2x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$117
|
$165B |
5.7x |
11.1x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$44
|
$127B |
2.7x |
8.0x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$408
|
$99.7B |
8.5x |
22.5x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$141
|
$67.9B |
7.2x |
16.4x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$460
|
$58.8B |
18.2x |
121.6x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$565
|
$55.1B |
3.9x |
11.5x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$162
|
$33.0B |
73.6x |
-33.2x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$147
|
$25.3B |
2.6x |
7.8x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.3B |
1.8x |
6.0x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$440
|
$16.8B |
5.3x |
10.2x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$15.6B |
N/A |
-43.2x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$84
|
$14.0B |
3.0x |
11.9x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$20
|
$13.5B |
3.0x |
15.4x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$137
|
$13.0B |
4.8x |
20.9x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$135
|
$12.0B |
2.9x |
11.4x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$11.7B |
28.2x |
-24.2x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$10.8B |
1.7x |
5.5x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$10.3B |
12.4x |
-25.3x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$9.7B |
4.2x |
11.7x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$52
|
$9.2B |
3.0x |
10.8x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$430
|
$8.9B |
12.3x |
-28.7x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$102
|
$8.6B |
3.3x |
-6.0x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$64
|
$8.5B |
6.7x |
10.3x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$8.3B |
N/A |
N/A |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$7.5B |
9.2x |
N/A |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$60
|
$7.2B |
103.4x |
-12.1x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$48
|
$7.0B |
1354.9x |
-7.1x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$101
|
$6.6B |
37.6x |
-33.7x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$16
|
$6.5B |
269.9x |
-6.2x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$94
|
$6.5B |
132.8x |
-19.3x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$21
|
$6.1B |
1.4x |
8.1x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$6.1B |
614.7x |
-10.5x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$27
|
$6.0B |
2.8x |
-1.6x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$122
|
$6.0B |
10.5x |
-36.0x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.6B |
1.9x |
8.5x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$5.4B |
10.1x |
41.2x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$88
|
$5.3B |
N/A |
-14.7x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$5.3B |
5.6x |
-40.2x |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$73
|
$5.1B |
175.4x |
-9.2x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$53
|
$5.0B |
N/A |
N/A |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$87
|
$4.9B |
33.8x |
-98.4x |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$181
|
$4.6B |
12.6x |
33.7x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$87
|
$4.4B |
66.5x |
-20.5x |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$4.3B |
6.0x |
103.0x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$4.2B |
2.9x |
11.4x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$61
|
$3.9B |
3.5x |
10.6x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.7B |
5.8x |
16.5x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$3.7B |
7.8x |
-132.1x |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$3.7B |
2.4x |
5.8x |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$54
|
$3.6B |
N/A |
-11.1x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$54
|
$3.6B |
2.4x |
6.1x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$3.6B |
1249.9x |
-9.9x |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$57
|
$3.5B |
48.0x |
-12.8x |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.5B |
N/A |
N/A |
uniQure
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$62
|
$3.5B |
133.2x |
-21.2x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$3.5B |
37.1x |
-33.0x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$3.4B |
99.1x |
N/A |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$3.3B |
3.4x |
65.8x |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$178
|
$3.2B |
15.8x |
43.3x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$3.2B |
28.2x |
N/A |
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$3.1B |
703.1x |
-7.0x |
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$52
|
$3.0B |
N/A |
-11.0x |
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$3.0B |
N/A |
-11.3x |
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$42
|
$2.9B |
N/A |
-15.1x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$2.9B |
1.4x |
-35.5x |
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$8
|
$2.8B |
4.6x |
34.6x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$20
|
$2.7B |
2.6x |
21.1x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$70
|
$2.7B |
7.1x |
-34.2x |
CG Oncology
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$2.6B |
1981.0x |
-14.9x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.6B |
29.2x |
N/A |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.6B |
4.1x |
-5.9x |
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$2.6B |
437.0x |
-7.5x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$38
|
$2.5B |
4.2x |
37.0x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$79
|
$2.5B |
N/A |
N/A |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$90
|
$2.4B |
3.1x |
11.7x |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$113
|
$2.4B |
8546.5x |
N/A |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$2.3B |
7.6x |
-42.2x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$25
|
$2.3B |
6.2x |
-22.3x |
Intellia Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$25
|
$2.3B |
37.4x |
-5.0x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$49
|
$2.3B |
3.3x |
16.4x |
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$2.3B |
N/A |
-4.7x |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$2.2B |
N/A |
-10.6x |
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$15
|
$2.2B |
9.8x |
-47.3x |
Ocular Therapeutix
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$12
|
$2.2B |
38.3x |
-8.9x |
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$2.2B |
1.6x |
11.0x |
Certara
|
United States of America |
Health Data & Analytics,
Drug Development & Therapeutics
|
$12
|
$2.0B |
4.9x |
15.8x |
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$23
|
$2.0B |
34.1x |
N/A |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$7
|
$2.0B |
3.3x |
25.7x |
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$46
|
$1.9B |
N/A |
-12.4x |
Recursion Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Bioinformatics,
Vertical AI Applications
|
$5
|
$1.9B |
27.5x |
-3.2x |
BGM Group
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$1.9B |
N/A |
N/A |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$20
|
$1.8B |
3.4x |
7.2x |
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$70
|
$1.8B |
N/A |
-9.2x |
89bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.7B |
N/A |
-4.6x |